Russian Journal of Bioorganic Chemistry

, Volume 44, Issue 1, pp 112–122 | Cite as

Dopamine Pretreatment Protects Offspring Rats from LPS-Induced Hypertension and Kidney Damage by Inhibiting NLRP3 Activation in Kidney

  • X. Q. Hao
  • C. F. Huang
  • F. Liang
  • W. Deng
  • Y. H. Ou
  • X. Zhang
  • L. Ding
  • D. Wang
  • S. T. Wang


This study was designed to explore the role of dopamine (DA) and NLRP3 in the mechanism of hypertension and renal impairment induced by prenatal exposure to lipopolysaccharide (LPS). Thirty pregnant rats were randomly divided into three groups, including control, LPS, and DA + LPS groups. Renal morphology changes were observed under microscope. The serum IL-1β and IL-18 concentration, mRNA, and protein expressions of NLRP3, ASC, and CASP1 in kidney of three-month old offspring rats were measured. Hematoxylin–eosin staining showed that the glomerular diameter decreased and cysts increased partly, glomerular balloons were adhered partly, there were moderate-to-severe hyperplasia dispersedly distributed in glomerular mesangial matrix in rats of LPS group. Serum IL-1β and IL-18 concentration in LPS group increased compared with control group and DA + LPS group. The average arterial pressure of offspring rats in LPS group increased significantly compared with control group and DA + LPS group. NLRP3 mRNA level in the LPS group increased significantly compared with the control group and the DA + LPS group in both male and female rats; NLRP3, ASC, and CASP1 protein expression in both renal cortex and renal medulla of LPS group increased significantly compared with control group and DA + LPS group in female rats. NLRP3 protein expression in LPS group increased significantly compared with control group and DA + LPS group in male rats. DA pretreatment exerts a protective effect on LPS-induced renal injury and hypertension in offspring rats, and the mechanism might be through inhibiting NLRP3 activation.


prenatal stress lipopolysaccharide hypertension dopamine NLRP3 inflammation 







essential hypertension


nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3


apoptosis-associated speck-like protein containing a caspase recruitment domain




pathogen-associated molecular patterns


danger-associated molecular patterns




dopamine 1 receptor


blood urea nitrogen


uric acid




enzyme-linked immunosorbent assay


hematoxylin and eosin


Toll-like receptor 4


acute kidney injury


ischemia/reperfusion injury


acute tubular necrosis


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    McKnight, A.J., Currie, D., and Maxwell, A.P., J. Pathol., 2010, vol. 220, no. 2, pp. 198–216.PubMedGoogle Scholar
  2. 2.
    Garrett, M.R., Pezzolesi, M.G., and Korstanje, R., J. Am. Soc. Nephrol., 2010, vol. 21, no. 3, pp. 398–405.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Ma, R.C., Tam, C.H., Wang, Y., Luk, A.O., Hu, C., Yang, X., Lam, V., Chan, A.W., Ho, J.S., Chow, C.C., Tong, P.C., Jia, W., Ng, M.C., So, W.Y., and Chan, J.C., J. Am. Med. Assoc., 2010, vol. 304, no. 8, pp. 881–889.CrossRefGoogle Scholar
  4. 4.
    Miliku, K., Vogelezang, S., Franco, O.H., Hofman, A., Jaddoe, V.W., and Felix, J.F., Pediatr. Res., 2016, vol. 80, no. 1, pp. 60–66.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Sahoo, M., Ceballos-Olvera, I., del Barrio, L., and Re, F., Sci. World J., 2011, vol. 11, pp. 2037–2050.CrossRefGoogle Scholar
  6. 6.
    Shirasuna, K., Karasawa, T., Usui, F., Kobayashi, M., Komada, T., Kimura, H., Kawashima, A., Ohkuchi, A., Taniguchi, S., and Takahashi, M., Endocrinology, 2015, vol. 156, no. 11, pp. 4281–4292.CrossRefPubMedGoogle Scholar
  7. 7.
    Hutton, H.L., Ooi, J.D., Holdsworth, S.R., and Kitching, A.R., Nephrology (Carlton), 2016, vol. 21, no. 9, pp. 736–744.CrossRefGoogle Scholar
  8. 8.
    Zhou, Y., Lu, M., Du, R.H., Qiao, C., Jiang, C.Y., Zhang, K.Z., Ding, J.H., and Hu, G., Mol. Neurodegener., 2016, vol. 11, no. 1, p. 28.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Li, X., Liu, S., Luo, J., Liu, A., Tang, S., Liu, S., Yu, M., and Zhang, Y., Pathog. Dis., 2015, vol. 73, no. 4, pii: ftu024. doi 10.1093/femspd/ftu024Google Scholar
  10. 10.
    Wan, H., Su, H., Wu, Y., Zhao, Y., and Zhou, M., Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2015, vol. 50, no. 2, pp. 145–150.PubMedGoogle Scholar
  11. 11.
    Li, Q., Zhang, X., Wang, W., Li, L., Xu, Q., Wu, X., and Gu, Y., Toxicol. Appl. Pharmacol., 2015, vol. 289, no. 2, pp. 133–141.CrossRefPubMedGoogle Scholar
  12. 12.
    Igreja, B., Wright, L.C., and Soares-da-Silva, P., J. Am. Soc. Hypertens., 2016, vol. 10, no. 3, pp. 207–216.CrossRefPubMedGoogle Scholar
  13. 13.
    Di Ciano, L.A., Azurmendi, P.J., Colombero, C., Levin, G., Oddo, E.M., Arrizurieta, E.E., Nowicki, S., and Ibarra, F.R., Am. J. Physiol. Renal. Physiol., 2015, vol. 308, no. 12, pp. F1358–F1368.CrossRefPubMedGoogle Scholar
  14. 14.
    Jiang, X., Chen, W., Liu, X., Wang, Z., Liu, Y., Felder, R.A., Gildea, J.J., Jose, P.A., Qin, C., and Yang, Z., PLoS One, 2016, vol. 11, no. 1, e0146641.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Yan, Y., Jiang, W., Liu, L., Wang, X., Ding, C., Tian, Z., and Zhou, R., Cell, 2015, vol. 160, no. 1–2, pp. 62–73.CrossRefPubMedGoogle Scholar
  16. 16.
    Hao, X.Q., Du, J.X., Li, Y., Li, M., and Zhang, S.Y., PLoS One, 2014, vol. 9, no. 2, e88127.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Huang, C.F., Du, J.X., Deng, W., Cheng, X.C., Zhang, S.Y., Zhao, S.J., Tao, M.J., Chen, G.Z., and Hao, X.Q., Neuroscience, 2015, vol. 286, pp. 364–370.CrossRefPubMedGoogle Scholar
  18. 18.
    Iyer, S.S., Pulskens, W.P., Sadler, J.J., Butter, L.M., Teske, G.J., Ulland, T.K., Eisenbarth, S.C., Florquin, S., Flavell, R.A., Leemans, J.C., and Sutterwala, F. S., Proc. Natl. Acad. Sci. U. S. A., 2009, vol. 106, no. 48, pp. 20388–20393.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Darisipudi, M.N. and Knauf, F., Pediatr. Nephrol., 2016, vol. 31, no. 4, pp. 535–544.CrossRefPubMedGoogle Scholar
  20. 20.
    Jose, P.A., Soares-da-Silva, P., Eisner, G.M., and Felder, R.A., Biochim. Biophys. Acta, 2010, vol. 1802, no. 12, pp. 1259–1267.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Zeng, C., Armando, I., Luo, Y., Eisner, G.M., Felder, R.A., and Jose, P.A., Am. J. Physiol. Heart. Circ. Physiol., 2008, vol. 294, no. 2, pp. H551–H569.CrossRefGoogle Scholar
  22. 22.
    Harrison, D.G., Guzik, T.J., Lob, H.E., Madhur, M.S., Marvar, P.J., Thabet, S.R., Vinh, A., and Weyand, C.M., Hypertension, 2011, vol. 57, no. 2, pp. 132–140.CrossRefPubMedGoogle Scholar
  23. 23.
    Wang, Y., Tay, Y.C., and Harris, D.C., Kidney Int., 2004, vol. 66, no. 2, pp. 655–662.CrossRefPubMedGoogle Scholar
  24. 24.
    Bendele, A.M., Spaethe, S.M., Benslay, D.N., and Bryant, H.U., J. Pharmacol. Exp. Ther., 1991, vol. 259, no. 1, pp. 169–175.PubMedGoogle Scholar
  25. 25.
    Bach, F., Grundmann, U., Bauer, M., Buchinger, H., Soltesz, S., Graeter, T., Larsen, R., and Silomon, M., Acta Anaesth. Scand., 2002, vol. 46, no. 10, pp. 1227–1235.CrossRefPubMedGoogle Scholar
  26. 26.
    Birnbaum, J., Klotz, E., Spies, C.D., Lorenz, B., Stuebs, P., Hein, O.V., Grundling, M., Pavlovic, D., Usichenko, T., Wendt, M., Kox, W.J., and Lehmann, C., Crit. Care, 2006, vol. 10, no. 4, p. R117.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Zhu, X.H., Zellweger, R., Wichmann, M.W., Ayala, A., and Chaudry, I.H., Cytokine, 1997, vol. 9, no. 6, pp. 437–446.CrossRefPubMedGoogle Scholar
  28. 28.
    Ghosh, M.C., Mondal, A.C., Basu, S., Banerjee, S., Majumder, J., Bhattacharya, D., and Dasgupta, P.S., Int. Immunopharmacol., 2003, vol. 3, no. 7, pp. 1019–1026.CrossRefPubMedGoogle Scholar
  29. 29.
    Hasko, G., Szabo, C., Nemeth, Z.H., and Deitch, E. A., J. Neuroimmunol., 2002, vol. 122, no. 1–2, pp. 34–39.CrossRefPubMedGoogle Scholar
  30. 30.
    Hoeger, S., Gottmann, U., Liu, Z., Schnuelle, P., Birck, R., Braun, C., van der Woude, F.J., and Yard, B.A., Transpl. Int., 2007, vol. 20, no. 9, pp. 790–799.CrossRefPubMedGoogle Scholar
  31. 31.
    Hoeger, S., Reisenbuechler, A., Gottmann, U., Doyon, F., Braun, C., Kaya, Z., Seelen, M.A., van Son, W.J., Waldherr, R., Schnuelle, P., and Yard, B.A., Transpl. Int., 2008, vol. 21, no. 11, pp. 1072–1080.PubMedGoogle Scholar
  32. 32.
    Zhang, M.Z., Yao, B., Wang, S., Fan, X., Wu, G., Yang, H., Yin, H., Yang, S., and Harris, R.C., J. Clin. Invest., 2011, vol. 121, no. 7, pp. 2845–2854.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Yang, S., Yao, B., Zhou, Y., Yin, H., Zhang, M.Z., and Harris, R.C., Am. J. Physiol. Renal. Physiol., 2012, vol. 302, no. 6, pp. F742–F749.CrossRefPubMedGoogle Scholar
  34. 34.
    Zeng, C., Sanada, H., Watanabe, H., Eisner, G.M., Felder, R.A., and Jose, P.A., Physiol. Genomics, 2004, vol. 19, no. 3, pp. 233–246.CrossRefPubMedGoogle Scholar
  35. 35.
    Jiang, X., Wang, W., Ning, B., Liu, X., Gong, J., Gan, F., Gao, X., Zhang, L., Jose, P.A., Qin, C., and Yang, Z., Clin. Exp. Hypertens., 2013, vol. 35, no. 1, pp. 74–78.CrossRefPubMedGoogle Scholar
  36. 36.
    Haney, M., Ward, A.S., Foltin, R.W., and Fischman, M.W., Psychopharmacology (Berl.), 2001, vol. 155, no. 4, pp. 330–337.CrossRefGoogle Scholar
  37. 37.
    Jose, P.A., Eisner, G.M., Drago, J., Carey, R.M., and Felder, R.A., Am. J. Hypertens., 1996, vol. 9, no. 4Pt 1, pp. 400–405.CrossRefPubMedGoogle Scholar
  38. 38.
    Wang, X., Luo, H., Chen, C., Chen, K., Wang, J., Cai, Y., Zheng, S., Yang, X., Zhou, L., Jose, P.A., and Zeng, C., Free Radic. Biol. Med., 2014, vol. 76, pp. 242–250.CrossRefPubMedGoogle Scholar

Copyright information

© Pleiades Publishing, Ltd. 2018

Authors and Affiliations

  • X. Q. Hao
    • 1
  • C. F. Huang
    • 1
  • F. Liang
    • 1
  • W. Deng
    • 1
  • Y. H. Ou
    • 1
  • X. Zhang
    • 1
  • L. Ding
    • 1
  • D. Wang
    • 1
  • S. T. Wang
    • 1
  1. 1.College of Animal Science and TechnologyHenan University of Science and TechnologyLuoyangChina

Personalised recommendations